{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-032387","form_type":"8-K","ticker":"VVOS","cik":"0001716166","company_name":"Vivos Therapeutics, Inc.","filed_at":"2026-07-07T21:29:42+00:00","discovered_at":"2026-07-07T21:32:00.285500+00:00","generated_at":"2026-07-07T21:32:06.774951+00:00","sec_items":["1.01","5.03","3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Vivos Therapeutics raises ~$2.1M in PIPE of convertible preferred and warrants","bullets":["Sold 3,608,496 units at $0.582/unit; each unit: one Series A Convertible Preferred (stated value $0.456) and one warrant (exercise $0.456, 5-year term).","Gross proceeds ~$2.1M; $1M cash, $1M from conversion of bridge note; net proceeds for working capital.","CEO R. Kirk Huntsman indirectly invested $50k via V-Co 4, an affiliate holding >9.99% of common stock.","Warrants immediately exercisable; beneficial ownership limits: 19.99% for V-Co 4, 9.99% (or 4.99%) for Bigger Capital.","Company must file resale registration statement within 45 days; Rights contingent on SEC effectiveness."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-032387","json":"https://secwatch.observer/filing/0001493152-26-032387.json","markdown":"https://secwatch.observer/filing/0001493152-26-032387.md","text":"https://secwatch.observer/filing/0001493152-26-032387.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1716166/000149315226032387/0001493152-26-032387-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1716166/000149315226032387/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-07T21:32:06.774951+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}